论文信息 - Phase II trial of the dual IGF-1R/IR inhibitor BMS-754807 with or without letrozole in aromatase inhibitor-resistant breast cancer. - 字舞流文

Phase II trial of the dual IGF-1R/IR inhibitor BMS-754807 with or without letrozole in aromatase inhibitor-resistant breast cancer.

A. Wolff | D. Nuyten | F. Huang | John W. Park | P. Haluska | M. Gottardis | J. Ingle | X. Hou | J. Carboni | A. Brodie | A. Dhar | F. Finckenstein | Fei Huang | J. Park